Home » Topics » Regulatory

Regulatory
RSS

FDA approves siltuximab for multicentric Castleman's disease

April 24, 2014

Incruse Ellipta approved in Canada for COPD

April 23, 2014

FDA approves ofatumumab in untreated chronic lymphocytic leukemia

April 22, 2014

Ragwitek sublingual immunotherapy approved by FDA for hay fever

April 22, 2014

Lilly's VEGF-inhibiting monoclonal antibody approved for gastric cancer

April 22, 2014

Dyax receives FDA approval to expand the use of Kalbitor

April 7, 2014

Subcutaneous MabThera approved in Europe for two forms of NHL

March 31, 2014

Albiglutide approved in Europe for type 2 diabetes

March 27, 2014

Samsca approved in Japan for autosomal dominant polycystic kidney disease

March 26, 2014

Tofogliflozin hydrate approved for type 2 diabetes in Japan

March 26, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...